• We specialize in small molecule inhibitors, agonists, antagonists and screening libraries!
Search Site
Home >> Signaling Pathways >> Cell Cycle/Checkpoint >> Chk >> MK-8776 (SCH-900776)
Related Products
MK-8776 (SCH-900776)Chk1 inhibitor,potent and selective

MK-8776 (SCH-900776)

Catalog No. A8477
Size Price Stock Qty
10mM (in 1mL DMSO) $121.00 In stock
5mg $110.00 In stock
10mg $160.00 In stock
50mg $450.00 In stock

Tel: +1-832-696-8203

Email: sales@apexbt.com

Worldwide Distributors

Sample solution is provided at 25 µL, 10mM.

Related Compound Libraries

Quality Control

Chemical structure


Biological Activity

Description SCH 900776 is a selective inhibitor of Chk1 with an IC50 value of 3 nM.
Targets Chk1 CDK2 Chk2      
IC50 3 nM 0.16 μM 1.5 μM      

MK-8776 (SCH-900776) Dilution Calculator

Concentration (start)
Volume (start)
Concentration (final)
Volume (final)


MK-8776 (SCH-900776) Molarity Calculator



Chemical Properties

Cas No. 891494-63-6 SDF Download SDF
Chemical Name 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine
Canonical SMILES CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4
Formula C15H18BrN7 M.Wt 376.25
Solubility >18.8mg/mL in DMSO Storage Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request


SCH 900776 is a potent and selective inhibitor of cell cycle checkpoint kinase 1 (Chk1), Chk2 and Cdk3 with IC50 value of 3 nM, 1.5µM and 0.16 µM, respectively.

Chk is s serine/threonine kinase that senses signal of DNA damage and stalls DNA replication, and also plays an essential role in the maintenance of replication fork viability during exposure to DNA antimetabolites.

In vitro, SCH 900776 blocked accumulation of the Chk1 pS296 autophosphorylation in a dose-dependent manner. Treatment of proliferating WS1 cells with SCH 900776 was found to be associated with rapid, dose-dependent accumulation of Chk1 pS345, indicating that cycling populations of normal cells induce Chk1 pS345 in response to the inhibition of SCH 900776 as part of a futile cycle 1.

In BALB/c mice, administration of SCH 900776 at a dosage of 8mg/kg after gemcitabine treatment can sufficiently induce enhanced tumor pharmacodynamic and regression responses as compared to gemcitabine or SCH 900776 alone 1.

1.   Guzi TJ, Paruch K, Dwyer MP, et al. Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high
content screening. Molecular cancer therapeutics. 2011;10(4):591-602.